These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7428822)

  • 1. Capping revisited. III. Differential inhibitory characteristics of the various cytochalasins.
    Loor F; Angman L
    Exp Cell Res; 1980 Oct; 129(2):289-95. PubMed ID: 7428822
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationship of thirty-nine cytochalasans observed in the effects on cellular structures and cellular events and on actin polymerization in vitro.
    Sekita S; Yoshihira K; Natori S; Harada F; Iida K; Yahara I
    J Pharmacobiodyn; 1985 Nov; 8(11):906-16. PubMed ID: 4093846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cytochalasins on lymphocytes. Identification of distinct cytochalasin-binding sites in relation to mitogenic response and hexose transport.
    Mookerjee BK; Cuppoletti J; Rampal AL; Jung CY
    J Biol Chem; 1981 Feb; 256(3):1290-300. PubMed ID: 7451506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro.
    Yahara I; Harada F; Sekita S; Yoshihira K; Natori S
    J Cell Biol; 1982 Jan; 92(1):69-78. PubMed ID: 7199054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochalasin D induces the capping of both leukaemia viral proteins and actin in infected cells.
    Mousa GY; Trevithick JR; Bechberger J; Blair DG
    Nature; 1978 Aug; 274(5673):808-9. PubMed ID: 567279
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of new cytochalasins from Phomopsis sp. and the derivatives on cellular structure and actin polymerization.
    Hirose T; Izawa Y; Koyama K; Natori S; Iida K; Yahara I; Shimaoka S; Maruyama K
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):971-4. PubMed ID: 2199089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochalasin A inhibits B-lymphocyte capping and activation by antigens.
    Teti G; La Via MF; Misefari A; Venza-Teti D
    Immunol Lett; 1981 Aug; 3(3):151-4. PubMed ID: 6974687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cytoskeleton-disrupting on the redistribution of the surface receptors of cultured cells].
    Khomenko AV; Pinaev GP
    Tsitologiia; 1983 Oct; 25(10):1137-44. PubMed ID: 6686355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capping of surface immunoglobulin on rabbit and mouse lymphocytes. II. Cytoskeletal involvement in different subpopulations.
    de Groot C; Wormmeester J; Mangnus-Smet C
    Eur J Cell Biol; 1981 Aug; 25(1):202-11. PubMed ID: 6974643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capping of cross-linked concanavalin A receptors on the surface of substrate-spread platelets.
    Alexandrova AY; Vasiliev JM
    Cell Motil; 1982; 2(2):163-71. PubMed ID: 7172220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differential effects of zinc on concanavalin A-induced capping of human lymphocytes.
    Rao KM
    Exp Gerontol; 1982; 17(3):205-11. PubMed ID: 7140861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents.
    Gelfand EW; Morris SA; Resch K
    J Immunol; 1975 Mar; 114(3):919-24. PubMed ID: 1112985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capping revisited. I. Inhibition by some thiols.
    Loor F
    Eur J Immunol; 1980 Jan; 10(1):53-7. PubMed ID: 7363936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for selective sulfhydryl reactivity in cytochalasin A--mediated bacterial inhibitions.
    Cunningham D; Flashner M; Tanenbaum SW
    Biochem Biophys Res Commun; 1979 Jan; 86(1):173-9. PubMed ID: 435298
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cytochalasins on lymphocytes: some distinctive features of cytochalasin-E.
    Mookerjee BK; Jung CY
    J Immunopharmacol; 1984; 6(3):185-203. PubMed ID: 6491312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capping revisited. II. Low sensitivity to sulfydryl reagents.
    Loor F; Martin-Pélissard C; Angman L
    Cell Immunol; 1981 Jan; 57(1):73-8. PubMed ID: 7214535
    [No Abstract]   [Full Text] [Related]  

  • 17. Cap formation by various ligands on lymphocytes shows the same dependence on high cellular ATP levels.
    Pozzan T; Corps AN; Montecucco C; Hesketh TR; Metcalfe JC
    Biochim Biophys Acta; 1980 Nov; 602(3):558-66. PubMed ID: 6776985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of ligand-independent cap formation induced in hypertonic medium.
    Yahara I; Kakimoto-Sameshima F
    Exp Cell Res; 1979 Mar; 119(2):237-52. PubMed ID: 311736
    [No Abstract]   [Full Text] [Related]  

  • 19. A role for cytochalasin-sensitive proteins in the regulation of calcium transport in activated human lymphocytes.
    Greene WC; Parker CW
    Biochem Biophys Res Commun; 1975 Jul; 65(2):456-63. PubMed ID: 167774
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of concanavalin A capping in phorbol ester-activated lymphocytes by calmodulin inhibitors and certain amino acid esters.
    Kwong CH; Mueller GC
    Cancer Res; 1982 Jun; 42(6):2115-20. PubMed ID: 7200397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.